[Chemotherapeutic activity of acetoxymethyl derivatives of di-N-oxides of quinoxaline in acute bacterial infections].
D000818:Animals; D001419:Bacteria / Q000187:drug effects / Q000254:growth & development; D002701:Chloramphenicol / Q000627:therapeutic use; D002751:Chlortetracycline / Q000627:therapeutic use; D003497:Cyclic N-Oxides / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D004405:Dysentery, Bacillary / Q000188:drug therapy; D004927:Escherichia coli Infections / Q000188:drug therapy; D066298:In Vitro Techniques; D007239:Infections / Q000188:drug therapy*; D007710:Klebsiella Infections / Q000188:drug therapy; D051379:Mice; D011512:Proteus Infections / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy; D011810:Quinoxalines / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D012481:Salmonella Infections, Animal / Q000188:drug therapy; D018805:Sepsis / Q000188:drug therapy*; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy
D003497:Cyclic N-Oxides; D011810:Quinoxalines; D002701:Chloramphenicol; D002751:Chlortetracycline
Khimioterapevticheskaia aktivnost' atsetoksimetil'nykh proizvodynkh di-N-okisi khinoksalima pri ostrykhbakterial'nykh infektsiiakh.